APT Medical Inc (688617) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.093x

Based on the latest financial reports, APT Medical Inc (688617) has a cash flow conversion efficiency ratio of 0.093x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.68 Million ≈ $43.12 Million USD) by net assets (CN¥3.18 Billion ≈ $465.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688617 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

APT Medical Inc - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how APT Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

APT Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of APT Medical Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Masan Group Corp
VN:MSN
0.032x
Cosan SA ADR
NYSE:CSAN
0.029x
Travere Therapeutics Inc
NASDAQ:TVTX
-0.409x
ExlService Holdings Inc
NASDAQ:EXLS
0.002x
Caesars Entertainment Corporation
NASDAQ:CZR
0.080x
Parq Arauco
SN:PARAUCO
0.027x
Broadstone Net Lease Inc
NYSE:BNL
0.025x
SOLV Energy, Inc. Class A Common Stock
NASDAQ:MWH
0.459x

Annual Cash Flow Conversion Efficiency for APT Medical Inc (2017–2025)

The table below shows the annual cash flow conversion efficiency of APT Medical Inc from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see how much is APT Medical Inc worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.18 Billion
≈ $465.03 Million
CN¥975.30 Million
≈ $142.72 Million
0.307x +5.47%
2024-12-31 CN¥2.55 Billion
≈ $373.85 Million
CN¥743.39 Million
≈ $108.78 Million
0.291x -17.15%
2023-12-31 CN¥1.96 Billion
≈ $287.10 Million
CN¥689.06 Million
≈ $100.83 Million
0.351x +71.18%
2022-12-31 CN¥1.79 Billion
≈ $262.09 Million
CN¥367.46 Million
≈ $53.77 Million
0.205x +102.58%
2021-12-31 CN¥1.79 Billion
≈ $262.09 Million
CN¥181.39 Million
≈ $26.54 Million
0.101x -69.25%
2020-12-31 CN¥450.09 Million
≈ $65.86 Million
CN¥148.24 Million
≈ $21.69 Million
0.329x +107.52%
2019-12-31 CN¥345.90 Million
≈ $50.62 Million
CN¥54.90 Million
≈ $8.03 Million
0.159x +130.60%
2018-12-31 CN¥270.70 Million
≈ $39.61 Million
CN¥18.63 Million
≈ $2.73 Million
0.069x +14.29%
2017-12-31 CN¥214.43 Million
≈ $31.38 Million
CN¥12.91 Million
≈ $1.89 Million
0.060x --

About APT Medical Inc

SHG:688617 China Medical Devices
Market Cap
$3.96 Billion
CN¥27.03 Billion CNY
Market Cap Rank
#4221 Global
#695 in China
Share Price
CN¥191.64
Change (1 day)
-2.42%
52-Week Range
CN¥191.64 - CN¥331.86
All Time High
CN¥453.00
About

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more